Guidance: Ambient voice technology-enabled products
Guidance on device qualification and classification of ambient voice technology-enabled products as medical devices in Great Britain.
UK MHRA · UKSince leaving the EU, the United Kingdom has run its own health regulatory regime. The Medicines and Healthcare products Regulatory Agency licenses medicines and regulates medical devices, including the UKCA marking and the future UK medical devices framework. NICE appraises the clinical and cost effectiveness of health technologies for the NHS. This page collects the UK regulatory updates HealthSignal tracks across medicines, devices, digital health, and health technology assessment, from official public sources only.
Guidance on device qualification and classification of ambient voice technology-enabled products as medical devices in Great Britain.
UK MHRA · UKMHRA guidance clarifies how medical device law applies to ambient voice technology products in UK health and care settings.
UK MHRA · UKGuidance to help manufacturers of digital mental health technologies determine regulatory qualification and appropriate device classification.
UK MHRA · UKFindings from the National Commission's call for evidence and research activities on AI regulation in healthcare.
UK MHRA · UKMHRA guidance on how it determines whether a borderline product meets the definition of a medical device and whether device regulations apply.
UK MHRA · UKMHRA enforcement notice requiring removal and quarantine of medical devices supplied without valid UKCA/CE markings or certification.
UK MHRA · UKMHRA establishes an Innovation Accelerator programme offering scientific expertise, regulatory guidance and enhanced advice to developers of innovative health products.
UK MHRA · UKMHRA invites expressions of interest from AI-enabled medical device manufacturers and NHS providers to participate in a regulatory sandbox.
UK MHRA · UKMHRA sets out data requirements and governance expectations for the UK Health Data Research Service to enable regulatory decision-making.
UK MHRA · UKExplains regulatory compliance requirements for manufacturers of custom-made medical devices.
UK MHRA · UKGuidance on management and use of point-of-care testing in vitro diagnostic devices.
UK MHRA · UKMHRA guidance on the approval process and criteria for clinical investigations of medical devices.
UK MHRA · UKMHRA guidance on transitional arrangements and timelines for accepting CE marked medical devices in GB.
UK MHRA · UKGuidance on interpreting post-market surveillance requirements for medical devices in Great Britain.
UK MHRA · UKUK MHRA National Commission is seeking evidence to shape regulation of AI in healthcare and support an AI-enabled NHS.
UK MHRA · UKMHRA seeks evidence on AI regulation in healthcare to inform the National Commission's recommendations.
UK MHRA · UKGuidance on investigator obligations and requirements for clinical investigations of medical devices under MHRA regulation.
UK MHRA · UKExplains how to determine whether a medical device requires a clinical investigation or qualifies for exemption under regulations.
UK MHRA · UKMHRA guidance on the regulatory framework and applicable legislation for medical device manufacturers and suppliers operating in Northern Ireland.
UK MHRA · UKMHRA provides standardised format and recommendations for manufacturers preparing post-market surveillance reports.
UK MHRA · UKMHRA publishes online resources to help the public and professionals understand safe, effective digital mental health technologies.
UK MHRA · UKPhase 2 of the Airlock programme will include seven additional AI-powered technologies for clinical documentation, cancer diagnostics, eye disease detection, and obesity treatment.
UK MHRA · UKMHRA publishes new pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the GB market and invites stakeholder views.
UK MHRA · UKMHRA seeks stakeholder evidence on proposed GB pre-market medical device and IVD regulation changes to inform impact assessment.
UK MHRA · UKMHRA invites views on proposals for recognising CE marked medical devices in Great Britain.
UK MHRA · UKThe Innovation Accelerator provides innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
UK MHRA · UKMHRA invites feedback on the use of designated standards for medical devices and IVD devices to inform future regulatory initiatives.
UK MHRA · UKEnhanced post-market surveillance requirements for all medical devices in Great Britain, including risk-proportionate systems, performance reporting, and shorter incident reporting timeframes.
UK MHRA · UKUK-specific medical device regulations enter into force, replacing EU directive-based system with enhanced post-market surveillance, software-update regulation, and AI-device requirements.
UK MHRA · UKMHRA invites suppliers to join Risk Ledger and complete security profiles to strengthen supply chain cyber security.
UK MHRA · UKNICE adapts its evidence standards framework for digital health technologies to support decision-making for digital care technologies in adult social care.
UK NICE · UKGuidance on how to notify the MHRA of a planned clinical investigation of a medical device.
UK MHRA · UKGuidance for manufacturers and distributors on the application process for COVID-19 test device approval in the UK market.
UK MHRA · UKIDAP pilot accelerates development and market integration of innovative medical devices addressing unmet NHS clinical needs.
UK MHRA · UKMHRA transitions from one-time device registration fees to annual category-based model, with mandatory registration updates by March 30, 2026 and annual fee payments from April 1, 2026.
UK MHRA · UKMHRA sets out deliverables and timelines to support safe development of in vitro diagnostic medical devices.
UK MHRA · UKWe can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
UK MHRA · UKGuidance on information requirements for notifying the MHRA of clinical investigation plans for electrically powered devices.
UK MHRA · UKGuidance on conducting biological safety evaluation required before undertaking clinical investigations for medical devices.
UK MHRA · UKGuidance on statistical data requirements for clinical investigations of medical devices.
UK MHRA · UKMHRA updated guidance on the Health Institution Exemption to help NHS Trusts and health institutions safely design and manufacture general medical devices.
UK MHRA · UKMHRA alerts to non-compliant medical devices on UK market lacking required conformity markings under UK MDR 2002 and EU MDR 2017/745.
UK MHRA · UKNew guidance for users of diabetes management equipment on reporting suspected adverse incidents and safety concerns via the Yellow Card scheme.
UK Drug Safety Update · UKGuidance on transitional arrangements for the Clinical Trials Regulations.
UK MHRA · UKGuidance on regulatory requirements applicable to prosthetic, orthotic and ophthalmic devices.
UK MHRA · UKMHRA publishes scientific assessment reports explaining the evidence and reasoning behind regulatory decisions on medicine safety.
UK MHRA · UKGuidance for health institutions manufacturing general medical devices under the Health Institution Exemption.
UK MHRA · UKGuidance on submitting applications for clinical trials that include an in vitro diagnostic device.
UK MHRA · UKHow to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).
UK MHRA · UKKeep up to date with the latest information from the UK GLP monitoring authority.
UK MHRA · UK